BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28060405)

  • 1. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Mol Biol; 2017 Jan; 117():16.17.1-16.17.18. PubMed ID: 28060405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Protein Sci; 2017 Aug; 89():5.13.1-5.13.18. PubMed ID: 28762491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.13. PubMed ID: 18429179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.17. PubMed ID: 18265124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Microbiol; 2015 Nov; 39():14A.4.1-14A.4.18. PubMed ID: 26528782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of recombinant vaccinia viruses and their products.
    Earl PL; Moss B
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.14. PubMed ID: 18429180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and evaluation of a new triple-gene expression cassette vaccinia virus shuttle vector.
    Du S; Li C; Wang Y; Liu C; Ren D; Li Y; Qin Y; Wang M; Sun D; Zhu N; Jin N
    J Virol Methods; 2012 Nov; 185(2):175-83. PubMed ID: 22766182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
    Zheng Q; Bi Z; Li M; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.
    Sutter G; Wyatt LS; Foley PL; Bennink JR; Moss B
    Vaccine; 1994 Aug; 12(11):1032-40. PubMed ID: 7975844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
    Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G
    Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
    Zheng Q; Li P; Cao R; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
    Ferrer MF; Zanetti FA; Calamante G
    Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts.
    Pfleiderer M; Falkner FG; Dorner F
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2957-62. PubMed ID: 8847500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
    Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
    Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new vaccinia recombinant plasmid pSC-O.
    Scheiflinger F; Bodemer W
    Gene; 1991 Dec; 109(2):307-8. PubMed ID: 1765277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recombinant vaccinia viruses and their products.
    Earl PL; Moss B
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.18. PubMed ID: 18265125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper.
    Timiryasova TM; Chen B; Fodor N; Fodor I
    Biotechniques; 2001 Sep; 31(3):534, 536, 538-40. PubMed ID: 11570497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.